Moderna is developing 2 new vaccines—and 1 could protect against the common cold
Health Magazine: Mark Cameron, associate professor at the School of Medicine, discussed expanding mRNA technology. “The U.S. population is aging and it’s not hard to predict that common cold viruses will wield an increasingly uncommon burden on our older adults, especially those in caregiving settings,” said Cameron. “Given the safety and efficacy of COVID-19 mRNA vaccines, especially in older adults, it’s welcome news that the companies who’ve made them are developing new programs to tackle other viral respiratory infections.”